This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mills, L. H. Articles by Zhu, B. T. Search for Related Content PubMed PubMed Citation Articles by Mills, L. H. Articles by Zhu, B. T.

Preferential Growth Stimulation of Mammary Glands over Uterine Endometrium in Female Rats by a Naturally Occurring Estradiol-17ß-fatty Acid Ester

Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina 29208 [L. H. M., A. J. L., B. T. Z.], and National Hormone and Pituitary Program, Harbor-University of California Los Angeles Medical Center, Torrance, California 90509 [A. F. P.]

We hypothesize that the endogenously present lipoidal estrogen fatty acid esters may have a stronger mitogenic action in the fat-rich mammary tissues than in the uterus. To test this hypothesis, we compared the activity of estradiol-17ß-stearate (E₂-17ß-S) with that of estradiol-17ß (E₂) in stimulating the growth of mammary glandular cells versus the growth of uterine endometrial cells in ovariectomized female Sprague Dawley rats. Experimentally, an estimated 0.5 or 5 nmol of E₂-17ß-S or E₂ was released daily to ovariectomized female rats through an Alzet pump implanted under the back skin of the animal for 10 or 23 days. The growth-stimulatory effect of E₂-17ß-S and E₂ on mammary glandular cells was determined according to 5-bromo-2'-deoxyuridine labeling indices, and their effect on the uterus was determined by measuring both the 5-bromo-2'-deoxyuridine labeling index and the uterine wet weight. Our results showed that chronic treatment of ovariectomized female rats with 0.5 or 5 nmol/day E₂-17ß-S for 10 or 23 days had a stronger stimulatory effect on mammary glandular cell proliferation than treatment with equimolar doses of E₂. In the uterus, however, E₂ was more active in stimulating the proliferation of uterine endometrial cells than E₂-17ß-S at equimolar doses. Our results demonstrated, for the first time, that a naturally occurring estradiol-17ß-fatty acid ester has a differential, strong mitogenic effect in the fat-rich mammary tissues, and this effect was not observed with E₂. It is tempting to suggest that the fatty acid esters of the endogenous estrogens and their bioactive metabolites (e.g., 4-hydroxyestradiol and 16-hydroxyestrone) may be of unique importance for stimulating cell growth and possibly also for inducing tumor formation in the fat-rich mammary tissues as compared with the uterus. More studies are warranted to test these ideas.

This article has been cited by other articles:

				M. Badeau, V. Vihma, T. S. Mikkola, A. Tiitinen, and M. J. Tikkanen Estradiol Fatty Acid Esters in Adipose Tissue and Serum of Pregnant and Pre- and Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4327 - 4331. [Abstract] [Full Text] [PDF]

				D. S. Park, H. Lee, P. G. Frank, B. Razani, A. V. Nguyen, A. F. Parlow, R. G. Russell, J. Hulit, R. G. Pestell, and M. P. Lisanti Caveolin-1-deficient Mice Show Accelerated Mammary Gland Development During Pregnancy, Premature Lactation, and Hyperactivation of the Jak-2/STAT5a Signaling Cascade Mol. Biol. Cell, October 1, 2002; 13(10): 3416 - 3430. [Abstract] [Full Text] [PDF]